Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells. - Test2 - elhamkhani - TriplyDB

Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells.

Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells.

http://www.wikidata.org/entity/Q34306998

about

Human cytokine-induced killer cells have enhanced in vitro cytolytic activity via non-viral interleukin-2 gene transfer "Adherent" versus Other Isolation Strategies for Expanding Purified, Potent, and Activated Human NK Cells for Cancer Immunotherapy Dendritic cells decreased the concomitant expanded Tregs and Tregs related IL-35 in cytokine-induced killer cells and increased their cytotoxicity against leukemia cells.Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer.Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy.Use of reporter genes for optical measurements of neoplastic disease in vivo Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitro Growth of human colorectal cancer SW1116 cells is inhibited by cytokine-induced killer cells.Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients.GMP-compliant, large-scale expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells in vitro and in vivo.Purified anti-CD3 × anti-HER2 bispecific antibody potentiates cytokine-induced killer cells of poor spontaneous cytotoxicity against breast cancer cells The clinical effects of dendritic cell vaccines combined with cytokine-induced killer cells intraperitoneal injected on patients with malignant ascites Effects of MICA expression on the prognosis of advanced non-small cell lung cancer and the efficacy of CIK therapy CIK cells from patients with HCC possess strong cytotoxicity to multidrug-resistant cell line Bel-7402/R Influence of murine mesenchymal stem cells on proliferation, phenotype, vitality, and cytotoxicity of murine cytokine-induced killer cells in coculture Visualizing the kinetics of tumor-cell clearance in living animals.Increased survival time of a patient with metastatic malignant melanoma following immunotherapy: A case report and literature review.Efficacy of adjuvant chemotherapy combined with immunotherapy with cytokine-induced killer cells for gastric cancer after d2 gastrectomy.Effect of inhibition proliferation in human lung adenocarcinoma A549 cells by cytokine-induced killer cells.Human CIK Cells Loaded with Au Nanorods as a Theranostic Platform for Targeted Photoacoustic Imaging and Enhanced Immunotherapy and Photothermal Therapy.Adjuvant cellular immunotherapy in patients with resected primary non-small cell lung cancer Cytokine-induced killer (CIK) cells: from basic research to clinical translation.Cord blood-derived cytokine-induced killer cellular therapy plus radiation therapy for esophageal cancer: a case report Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safety Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection.Inhibition of human pancreatic tumor growth by cytokine-induced killer cells in nude mouse xenograft model.Cytokine-induced killer cells promote antitumor immunity Potential for enhanced therapeutic activity of biological cancer therapies with doxycycline combination Cytokine-induced killer cell therapy for advanced pancreatic adenocarcinoma: A case report and review of the literature In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity Cytotoxicity of cytokine-induced killer cells targeted by a bispecific antibody to gastric cancer cells.IL-12 enhances efficacy and shortens enrichment time in cytokine-induced killer cell immunotherapy Cholangiocarcinoma-derived exosomes inhibit the antitumor activity of cytokine-induced killer cells by down-regulating the secretion of tumor necrosis factor-α and perforin.Retargeting cytokine-induced killer cell activity by CD16 engagement with clinical-grade antibodies.Effect of anti-asthma Chinese medicine Chuankezhi on the anti-tumor activity of cytokine-induced killer cells.Autologous CIK cell immunotherapy in patients with renal cell carcinoma after radical nephrectomy.Profiling the dynamic expression of checkpoint molecules on cytokine-induced killer cells from non-small-cell lung cancer patients.Early efficacy of stereotactic body radiation therapy combined with adoptive immunotherapy for advanced malignancies In vivo proof of concept of adoptive immunotherapy for hepatocellular carcinoma using allogeneic suicide gene-modified killer cells.Clinical studies applying cytokine-induced killer cells for the treatment of gastrointestinal tumors.

P2860

Q24804905-51202C1A-4384-488E-8DFF-FEDB358703F4 Q28081338-86C8755F-E306-416D-9649-24571C76EA1E Q31157715-32E54BE8-3837-4C31-98E7-F5C63563C91C Q33429758-DA7E2EFC-34D0-476A-BE2F-866AD790ED9B Q33875615-A894E9F4-6768-4ED5-B30A-91DE9579FD4C Q33995764-5CC083D0-A00F-444D-A61B-7AD78386635E Q34128227-2CDF54FD-6066-4EC9-8C7D-1262DBDD439F Q34382415-E47ECFAB-2BC6-4B46-9A17-0BCC086476E1 Q34450648-A94E4872-4EDE-4D75-AD30-03877F0453D9 Q34551581-EAA491F8-726A-4653-8FBF-C247DB00C911 Q34643044-4F8E719B-6B59-4996-82F0-CEBF4A4DC55B Q34769958-D84A62F3-2A1C-491A-9F4A-8E605C544B57 Q34918975-0E9FD6FC-2034-46D5-8CB9-C0149979D322 Q35045325-DF20D5EB-AD81-458D-BBF3-DD97618F9FCC Q35091555-EE45004F-A25E-41A2-91EC-7FCD6E822A03 Q35731839-B61A1A4D-43B7-49AB-A06F-30930954BA34 Q35870544-F00112FB-85A8-4061-96AF-461574B7D496 Q35870886-F5030C9F-8F87-4278-B953-30CBA3453F5A Q35879402-4BF2361F-11C5-4268-BD61-9AACB4C6CA69 Q36043634-6BE76335-0BD0-486D-A1ED-562EDEF73C26 Q36060352-5F16B9B3-9D95-4B9F-8945-6EE4A11CCBE5 Q36121153-AC003837-3392-46EA-BE3F-5F3EDE35AF20 Q36153869-14480FF0-60B8-40E6-BD72-010FA0FE5AB4 Q36444510-0314D0CC-0AF7-42F0-A694-88686F9C1C6A Q36566943-78ED3054-65C6-47C3-BD30-250E96C05674 Q36592772-A68037DA-0A8E-4692-89CE-BCDCBEA9D68A Q36741617-3D2AA082-D201-490B-AF0D-0F83C406EB91 Q36750814-50A417ED-38D0-47A6-83AB-DAE4A999AB0B Q36774574-DF0965F3-8E04-4051-8498-204E6297E332 Q36868792-AD7CD9C8-8A1F-4237-B808-C2027BA06BBC Q36981154-9BAB2633-43E3-42EA-A165-5886F4E4CCEB Q37041732-3CD09633-1103-4D61-A4CB-6161E6A8CA1E Q37084575-BFC5DE31-BC5A-4FAB-9D11-BDA2B29A2AAD Q37224604-597F7CC7-8E44-4ED8-BD81-438845917BA8 Q37353913-D9EEA877-5B7B-4228-BCB3-9366728A2931 Q37412513-55EC1A82-11DD-46E9-9624-58CBB0230657 Q37536649-DD0537B2-E5B6-4582-BA9B-0CF14A94AF0C Q37560863-92B4ECA4-6AB0-4203-9D07-5F176A64156F Q37620831-C6505D19-473D-432D-A188-6299CC095417 Q37704879-E1EE0030-3BEC-4B8E-9FA6-72D2BC7ACD72

P2860

Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells.

http://www.wikidata.org/entity/Q34306998

description

1993 nî lūn-bûn

@nan

1993 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1993 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1993年の論文

@ja

1993年論文

@yue

1993年論文

@zh-hant

1993年論文

@zh-hk

1993年論文

@zh-mo

1993年論文

@zh-tw

1993年论文

@wuu

name

Phenotypic characterization an ...... cytokine-induced killer cells.

@ast

Phenotypic characterization an ...... cytokine-induced killer cells.

@en

Phenotypic characterization an ...... cytokine-induced killer cells.

@nl

type

label

Phenotypic characterization an ...... cytokine-induced killer cells.

@ast

Phenotypic characterization an ...... cytokine-induced killer cells.

@en

Phenotypic characterization an ...... cytokine-induced killer cells.

@nl

prefLabel

Phenotypic characterization an ...... cytokine-induced killer cells.

@ast

Phenotypic characterization an ...... cytokine-induced killer cells.

@en

Phenotypic characterization an ...... cytokine-induced killer cells.

@nl

P1433

Q34306998-8943490F-95B1-4D51-8E61-743024F38781

P1476

Q34306998-156980FB-86D3-46EF-8DE1-AE211901DB2C

P2093

Q34306998-1EC8A3A1-E517-44DB-9533-1675C2091E33

Q34306998-2B35B594-DE00-48E9-90EE-E51A7FD4CED6

Q34306998-466B2415-67DA-45E3-8C7D-195D846CAA0E

Q34306998-46C27828-9D8B-4621-B628-72C1A3DE8644

Q34306998-9BEBC490-294D-45C3-A3E2-4615D6FFA125

Q34306998-A7604597-C645-491A-8D4A-A63C354552B0

Q34306998-BD51D379-955E-4178-87EC-C7137FEB9743

Q34306998-FB21FD46-6913-45A1-97AF-D508623448DA

P304

Q34306998-31C58D27-CA26-41E9-9B37-2524471F4A60

P31

Q34306998-114AD435-7E91-4494-8948-53557F4FBCA1

P433

Q34306998-3BF9B470-46E6-4DE7-B895-D37DD635D904

P478

Q34306998-1514FA2B-2B7D-4598-8769-2A8FC1FA016C

P577

Q34306998-E0A636C1-41E8-4531-9E2B-45CF63B5BE6C

P698

Q34306998-E6F7FEAF-4018-4926-AC66-925265D8E1AF

P1433

Experimental Hematology

P1476

Phenotypic characterization an ...... cytokine-induced killer cells

@en

P2093

Blume KG

http://www.w3.org/2001/XMLSchema#string

Fernandez LP

http://www.w3.org/2001/XMLSchema#string

Huhn D

http://www.w3.org/2001/XMLSchema#string

Lefterova P

http://www.w3.org/2001/XMLSchema#string

Mehta BA

http://www.w3.org/2001/XMLSchema#string

Negrin RS

http://www.w3.org/2001/XMLSchema#string

Schmidt-Wolf IG

http://www.w3.org/2001/XMLSchema#string

Weissman IL

http://www.w3.org/2001/XMLSchema#string

P304

1673-1679

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

1993-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

7694868

http://www.w3.org/2001/XMLSchema#string